Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis

Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 5, 2008, Pages 682-687

  Stewart, Rosemary A ^a   Ram, Bhaskar ^a   Hamilton, Garun ^b   Weiner, John ^b   Kane, Kevin J ^a  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; MONTELUKAST; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; FACE PAIN; FEMALE; HEADACHE; HUMAN; MALE; MONOTHERAPY; NOSE POLYP; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SNEEZING; STEROID THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

ACETATES; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BUDESONIDE; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; NASAL POLYPS; PREDNISOLONE; QUINOLINES; TREATMENT OUTCOME;

EID: 54549110118     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2008.07.010     Document Type: Article

References (23)

1. O'Byrne P.M., Israel E., and Drazen J.M. Antileukotrienes in the treatment of asthma. Ann Intern Med 127 (1997) 472-480
2. Claesson H.E., and Dahlen S.E. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. J Intern Med 245 (1999) 205-227
3. Israel E., Cohn J., Dube L., et al. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. J Am Med Assoc 275 (1996) 931-936
4. Liu M.C., Dube L.M., and Lancaster J. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. J Allergy Clin Immunol 98 (1996) 859-871
5. Spector S.L., Smith L.J., and Glass M. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. Am J Respir Crit Care 150 (1994) 618-623
6. 4) receptor antagonist, in patients with chronic asthma. J Allergy Clin Immunol 98 (1996) 528-534
7. Lipworth B.J. Emerging role of antileukotriene therapy in allergic rhinitis. Clin Exp Allergy 31 (2001) 1813-1821
8. Nayak A.S., Philip G., Lu S., et al. Efficacy and tolerability of montelukast alone or in combination with loratidine in seasonal allergic rhinitis: a multi-center, randomized double-blind placebo-controlled trial performed in the Fall. Ann Allergy Asthma Immunol 88 (2002) 592-600
9. Philip G., Malmstrom K., Hampel Jr. F.C., et al. Montelukast for treating seasonal allergic rhinitis: a randomised, double-blind, placebo-controlled trial performed in the spring. Montelukast Spring Rhinitis Study Group. Clin Exp Allergy 32 (2002) 1020-1028
10. Baenkler H.W., Schafer D., and Hosemann W. Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhinology 1 (1996) 166-170
11. Ogino S., Irifune M., Harada T., et al. Arachidonic acid metabolites in human nasal polyps. Acta Otolaryngol Suppl 501 (1993) 85-87
12. Klapan I., Culo F., Culig J., et al. Arachidonic acid metabolites and sinonasal polyposis I. Possible prognostic value. Am J Otolaryngol 16 (1995) 396-402
13. Cohn J.R., Keane W.M., and Branton C.F. Treatment of refractory nasal polyps with leukotriene inhibitors/antagonists. J Allergy Clin Immunol 103 (1999) S256 (in Soc Proc)
14. Ulualp S.O., Sterman B.M., and Toohill R.J. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Ear Nose Throat J 78 (1999) 604-616
15. Parnes S.M., and Chuma A.V. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 79 (2000) 18-25
16. DiRienzo L., Artuso A., and Cerqua N. Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome. Acta Otorhinolaryngol Ital 20 (2000) 336-342
17. Grundmann T., and Topfner M. Treatment of ASS-associated polyposis (ASSAP) with a cysteinyl leukotriene receptor antagonist: a prospective drug study on its anti-inflammatory effects. Laryngorhinootologie 80 (2001) 576-582
18. Wobst B., Reichert K., Scherer H., et al. Clinical study about the effectiveness of montelukast in patients with nasal polyps with and without bronchial asthma and aspirin intolerance. Allergy 55 Suppl 63 (2000) 41 (in Soc Proc)
19. Ragab S., Parikh A., Darby Y.C., et al. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 31 (2001) 1385-1391
20. Kutting B., Nieschalk M., and Brehler R. A new concept for treatment of sinonasal polyposis. Allergy 11 (2000) 1091-1092
21. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
22. Lund V.J., and Kennedy D.W. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol 104 Suppl 167 (1995) 17-21
23. Kieff D.A., and Busaba N.Y. Efficacy of montelukast in the treatment of nasal polyposis. Ann Otol Rhinol Laryngol 114 (2005) 941-945